CPB Budapest 2017

Primary radiotherapy

• Stage I/II: Low/intermediate risk  BRACHYTHERAPY alone

• Stage I/II:

High risk

• Stage III & IV  External beam to CTV including whole uterus and pelvic nodes: 45 - 50.4Gy  BRACHYTHERAPY boost